589 related articles for article (PubMed ID: 30031018)
21. Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease - interim results of an international multicentre trial.
Kappelle WF; Bredenoord AJ; Conchillo JM; Ruurda JP; Bouvy ND; van Berge Henegouwen MI; Chiu PW; Booth M; Hani A; Reddy DN; Bogte A; Smout AJ; Wu JC; Escalona A; Valdovinos MA; Torres-Villalobos G; Siersema PD
Aliment Pharmacol Ther; 2015 Sep; 42(5):614-25. PubMed ID: 26153531
[TBL] [Abstract][Full Text] [Related]
22. Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease.
Schwameis K; Nikolic M; Morales Castellano DG; Steindl A; Macheck S; Kristo I; Zörner B; Schoppmann SF
World J Surg; 2018 Oct; 42(10):3263-3269. PubMed ID: 29619511
[TBL] [Abstract][Full Text] [Related]
23. Laparoscopic Magnetic Sphincter Augmentation vs Laparoscopic Nissen Fundoplication: A Matched-Pair Analysis of 100 Patients.
Reynolds JL; Zehetner J; Wu P; Shah S; Bildzukewicz N; Lipham JC
J Am Coll Surg; 2015 Jul; 221(1):123-8. PubMed ID: 26095560
[TBL] [Abstract][Full Text] [Related]
24. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease.
Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oksenberg D; Perez-Castilla A; Netto MG; Soffer E; Crowell MD
Endoscopy; 2013 Aug; 45(8):595-604. PubMed ID: 23881803
[TBL] [Abstract][Full Text] [Related]
25. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
Yadlapati R; Gyawali CP; Pandolfino JE;
Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
[TBL] [Abstract][Full Text] [Related]
26. Hiatal hernia recurrence following magnetic sphincter augmentation and posterior cruroplasty: intermediate-term outcomes.
Rona KA; Tatum JM; Zehetner J; Schwameis K; Chow C; Samakar K; Dobrowolsky A; Houghton CC; Bildzukewicz N; Lipham JC
Surg Endosc; 2018 Jul; 32(7):3374-3379. PubMed ID: 29340828
[TBL] [Abstract][Full Text] [Related]
27. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
28. Non-active implantable device treating acid reflux with a new dynamic treatment approach: 1-year results : RefluxStop™ device; a new method in acid reflux surgery obtaining CE mark.
Bjelović M; Harsányi L; Altorjay Á; Kincses Z; Forsell P;
BMC Surg; 2020 Jul; 20(1):159. PubMed ID: 32689979
[TBL] [Abstract][Full Text] [Related]
29. Early results of magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: Systematic review and meta-analysis.
Aiolfi A; Asti E; Bernardi D; Bonitta G; Rausa E; Siboni S; Bonavina L
Int J Surg; 2018 Apr; 52():82-88. PubMed ID: 29471155
[TBL] [Abstract][Full Text] [Related]
30. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
[TBL] [Abstract][Full Text] [Related]
31. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
32. S148: Long-term patient-reported outcomes of laparoscopic magnetic sphincter augmentation versus Nissen fundoplication: a 5-year follow-up study.
O'Neill SM; Jalilvand AD; Colvin JS; Haisley KR; Perry KA
Surg Endosc; 2022 Sep; 36(9):6851-6858. PubMed ID: 35041056
[TBL] [Abstract][Full Text] [Related]
33. Six to 12-year outcomes of magnetic sphincter augmentation for gastroesophageal reflux disease.
Ferrari D; Asti E; Lazzari V; Siboni S; Bernardi D; Bonavina L
Sci Rep; 2020 Aug; 10(1):13753. PubMed ID: 32792508
[TBL] [Abstract][Full Text] [Related]
34. Nissen fundoplication
Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
[TBL] [Abstract][Full Text] [Related]
35. pH Impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures.
Carroll TL; Fedore LW; Aldahlawi MM
Laryngoscope; 2012 Nov; 122(11):2473-81. PubMed ID: 22965767
[TBL] [Abstract][Full Text] [Related]
36. Magnetic sphincter augmentation: a viable rescue therapy for symptomatic reflux following bariatric surgery.
Broderick RC; Smith CD; Cheverie JN; Omelanczuk P; Lee AM; Dominguez-Profeta R; Cubas R; Jacobsen GR; Sandler BJ; Fuchs KH; Horgan S
Surg Endosc; 2020 Jul; 34(7):3211-3215. PubMed ID: 31485930
[TBL] [Abstract][Full Text] [Related]
37. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
[TBL] [Abstract][Full Text] [Related]
39. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
Abdallah J; George N; Yamasaki T; Ganocy S; Fass R
Clin Gastroenterol Hepatol; 2019 May; 17(6):1073-1080.e1. PubMed ID: 29913281
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
